Start Forschung Publikationen Publikationen

Publikationen

2020

 
Becker K, Banaschewski T, Brandeis D, Dose C, Hautmann C, Holtmann M, Jans T, Jendreizik L, Jenkner C, John K, Ketter J, Millenet S, Pauli-Pott U, Renner T, Romanos M, Treier AK, von Wirth E, Wermter AK, Döpfner M. Individualised stepwise adaptive treatment for 3-6-year-old preschool children impaired by attention-deficit/hyperactivity disorder (ESCApreschool): study protocol of an adaptive intervention study including two randomised controlled trials within the con. Trials 2020 21(1):56.
Chadwick VL, Rohleder C, Koethe D, Leweke FM. Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans. Curr Opin Psychiatry 2020 33(1):20-42. Epub 2019 Nov 9.
Deschamps P, Hebebrand J, Jacobs B, Robertson P, Anagnostopoulos DC, Banaschewski T, Birkle SM, Dubicka B, Falissard B, Giannopoulou I, Hoekstra PJ, Kaess M, Kapornai K, Klauser P, Revet A, Schröder CM, Seitz J, Şeker A, Signorini G. Training for child and adolescent psychiatry in the twenty-first century. Eur Child Adolesc Psychiatry 2020 Jan 16. [Epub ahead of print]
Fehlner P, Bilek E, Harneit A, Böhringer A, Moessnang C, Meyer-Lindenberg A, Tost H. Neural responses to social evaluative threat in the absence of negative investigator feedback and provoked performance failures. Hum Brain Mapp 2020 Jan 20. [Epub ahead of print]
Feld G, Born J. Neurochemical mechanisms for memory processing during sleep: basic findings in humans and neuropsychiatric implications. Neuropsychopharmacology 2020 45(1):31-44. Epub 2019 Aug 23.
Geissler JM, Vloet TD, Strom N, Jaite C, Graf E, Kappel V, Warnke A, Jacob C, Hennighausen K, Haack-Dees B, Schneider-Momm K, Matthies S, Rösler M, Retz W, Hänig S, von Gontard A, Sobanski E, Alm B, Hohmann S, Poustka L, Colla M, Gentschow L, Freitag CM, Häge A, Holtmann M, Becker K, Philipsen A, Jans T. Correction to: Does helping mothers in multigenerational ADHD also help children in the long run? 2‑year follow‑up from baseline of the AIMAC randomized controlled multicentre trial. Eur Child Adolesc Psychiatry 2020 Jan 2. [Epub ahead of print]
Hajek A, Brettschneider C, Lühmann D, van den Bussche H, Oey A, Wiese B, Weyerer S, Werle J, Fuchs A, Pentzek M, Gühne U, Riedel-Heller SG, Weeg D, Bickel H, Heser K, Wagner M, Maier W, Scherer M, Röhr S, König H. [Does an Increase in Depressive Symptoms Lead to an Increase in Functional Impairment or vice versa? Results of the AgeCoDe and AgeQualiDe Study]. Psychiatr Prax 2020 Jan 17. [Epub ahead of print]
Krause-Utz A, Walther J, Schweizer S, Lis S, Hampshire A, Schmahl C, Bohus M. Effectiveness of an Emotional Working Memory Training in Borderline Personality Disorder: A Proof-of-Principle Study. Psychother Psychosom 2020 Jan 3. [Epub ahead of print]
López-Pelayo H, Zuluaga P, Caballeria E, van den Brink W, Mann KF, Gual A. Safety of nalmefene for the treatment of alcohol use disorder: an update. Expert Opin Drug Saf 2020 19(1):9-17.
Mehren A, Reichert M, Coghill D, Müller HHO, Braun N, Philipsen A. Physical exercise in attention deficit hyperactivity disorder - evidence and implications for the treatment of borderline personality disorder. BPDED 2020 7:1.
Schirmbeck F, Konijn M, Hoetjes V, Vermeulen J, Zink M, Dekker J, de Haan L, for GROUP . Stressful experiences affect the course of co-occurring obsessive-compulsive and psychotic symptoms: A focus on within-subject processes. Schizophr Res 2020 Jan 7. [Epub ahead of print]
Strosche A, Zhang X, Kirsch M, Hermann D, Ende G, Kiefer F, Vollstädt-Klein S. Investigation of brain functional connectivity to assess cognitive control over cue-processing in Alcohol Use Disorder. Addict Biol 2020 Jan 6. [Epub ahead of print]
Wenzel J, Hansen CE, Bettoni C, Vogt MA, Lembrich B, Natsagdorj R, Huber G, Brands J, Schmidt K, Assmann JC, Stölting I, Saar K, Sedlacik J, Fiehler J, Ludewig P, Wegmann M, Feller N, Richter M, Müller-Fielitz H, Walther T, König GM, Kostenis E, Raasch W, Hubner N, Gass P, Offermanns S, de Wit C, Wagner CA, Schwaninger M. Impaired endothelium-mediated cerebrovascular reactivity promotes anxiety and respiration disorders in mice. Proc Natl Acad Sci U S A 2020 Jan 2. [Epub ahead of print]

2019

 
Abzieher P, Lipp M, Staats JH, Banaschewski T, Driessen M, Karow A. [Treatment in Adolescent Psychiatry: Results of a Germany-wide Survey]. Fortschr Neurol Psychiatr 2019 87(11):645-652.
Adorjan K, Mekonnen Z, Tessema F, Ayana M, Degenhardt F, Hoffmann P, Fricker N, Widmann M, Riedke H, Toennes S, Soboka M, Suleman S, Andlauer TFM, Tesfaye M, Rietschel M, Susser E, Odenwald M, Schulze TG, Mattheisen M. Genotype-phenotype feasibility studies on khat abuse, traumatic experiences and psychosis in Ethiopia. Psychiatr Genet 2019 Sep 18. [Epub ahead of print]
Aggensteiner PM, Brandeis D, Millenet S, Hohmann S, Ruckes C, Beuth S, Albrecht B, Schmitt G, Schermuly S, Wörz S, Gevensleben H, Freitag CM, Banaschewski T, Rothenberger A, Strehl U, Holtmann M. Slow cortical potentials neurofeedback in children with ADHD: comorbidity, self-regulation and clinical outcomes 6 months after treatment in a multicenter randomized controlled trial. Eur Child Adolesc Psychiatry 2019 28(4):1087-1095. Epub 2019 Jan 4.
Akkermans SEA, Rheinheimer N, Bruchhage MMK, Durston S, Brandeis D, Banaschewski T, Boecker-Schlier R, Wolf I, Williams SC, Buitelaar JK, Van Rooij D, Oldehinkel M, TACTICS consortium . Frontostriatal functional connectivity correlates with repetitive behaviour across autism spectrum disorder and obsessive-compulsive disorder. Psychol Med 2019 49(13):2247-2255. Epub 2018 Oct 26.
Albaugh MD, Hudziak JJ, Ing A, Chaarani B, Barker E, Jia T, Lemaitre H, Watts R, Orr C, Spechler PA, Lepage C, Fonov V, Collins L, Rioux P, Evans AC, Banaschewski T, Bokde AL, Bromberg U, Büchel C, Quinlan EB, Desrivieres S, Flor H, Frouin V, Gowland P, Heinz A, Ittermann B, Martinot JL, Nees F, Orfanos DP, Paus T, Poustka L, Fröhner JH, Smolka MN, Walter H, Whelan R, Schumann G, Garavan H, Potter A. White matter microstructure is associated with hyperactive/inattentive symptomatology and polygenic risk for attention-deficit/hyperactivity disorder in a population-based sample of adolescents. Neuropsychopharmacology 2019 44(9):1597-1603. Epub 2019 Apr 6.
Albaugh MD, Ivanova M, Chaarani B, Orr C, Allgaier N, Althoff RR, D' Alberto N, Hudson K, Mackey S, Spechler PA, Banaschewski T, Brühl R, Bokde AL, Bromberg U, Büchel C, Cattrell A, Conrod PJ, Desrivieres S, Flor H, Frouin V, Gallinat J, Goodman R, Gowland P, Grimmer Y, Heinz A, Kappel V, Martinot JL, Martinot MP, Nees F, Papadopoulos Orfanos D, Penttilä J, Poustka L, Paus T, Smolka MN, Struve M, Walter H, Whelan R, Schumann G, Garavan H, Potter AS. Ventromedial Prefrontal Volume in Adolescence Predicts Hyperactive/Inattentive Symptoms in Adulthood. Cereb Cortex 2019 29(5):1866-1874. Epub 2018 Apr 18.
Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, Brandt CL, Cervenka S, Djurovic S, Doan NT, Eisenacher S, Fatouros-Bergman H, Flyckt L, Di Giorgio A, Haatveit B, Jönsson EG, Kirsch P, Lund MJ, Meyer-Lindenberg A, Pergola G, Schwarz, Ph.D E, Smeland OB, Quarto T, Zink M, Andreassen OA, Westlye LT, Karolinska Schizophrenia Project Consortium . Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. JAMA Psychiatry 2019 76(7):739-748. Epub 2019 Apr 10.
Anderson-Schmidt H, Gade K, Malzahn D, Papiol S, Budde M, Heilbronner U, Reich-Erkelenz D, Adorjan K, Kalman JL, Senner F, Comes AL, Flatau L, Gryaznova A, Hake M, Reitt M, Schmauß M, Juckel G, Reimer J, Zimmermann J, Figge C, Reininghaus E, Anghelescu IG, Konrad C, Thiel A, von Hagen M, Koller M, Stierl S, Scherk H, Spitzer C, Folkerts H, Becker T, Dietrich DE, Andlauer TFM, Degenhardt F, Nöthen MM, Witt S, Rietschel M, Wiltfang J, Falkai P, Schulze TG. The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia. Schizophr Res 2019 210:255-261. Epub 2019 Jan 3.
Andlauer TFM, Guzman-Parra J, Streit F, Strohmaier J, Gonzalez MJ, Gil Flores S, Cabaleiro Fabeiro FJ, Del Río Noriega F, Perez FP, Haro González J, Orozco Diaz G, de Diego-Otero Y, Moreno-Küstner B, Auburger G, Degenhardt F, Heilmann-Heimbach S, Herms S, Hoffmann P, Frank J, Foo JC, Treutlein J, Witt S, Cichon S, Kogevinas M, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium , Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium , Rivas F, Mayoral F, Müller-Myhsok B, Forstner AJ, Nöthen MM, Rietschel M. Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders. Mol Psychiatry 2019 Nov 11. [Epub ahead of print]
Anton RF, Witkiewitz K, Falk D, Litten R, Hasin D, Mann KF, O'Malley S, Alcohol Clinical Trial Workgroup (ACTIVE) . Response to Dr. Mark Litt's Commentary. Alcohol Clin Exp Res 2019 43(10):2255-2256. Epub 2019 Aug 5.
Aubin HJ, Mann KF. Medication development: reducing casualties in the valley of death and providing support for survivors. Alcohol Clin Exp Res 2019 43(1):22-52. Epub 2018 Nov 11.
Augustin M, Schoretsanitis G, Pfeifer P, Gründer G, Liebe C, Paulzen M. Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations. Schizophr Res 2019 210:143-148. Epub 2019 Jun 7.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de